Salk Institute

Technologies Available for Licensing

FLP-Mediated Gene Modification in Mammalian Cells, and Compositions and Cells Useful Therefor

Inventors: Geoff Wahl and Stephen O'Gorman
Potential Uses: Gene Expression
Rapid and precise site-specific recombination in mammalian cells

The invention relates to methods for the site-specific recombination of DNA in mammalian cells or host mammalian organisms and is based on the recombination of transfected sequences by FLP, a recombinase derived from Saccharomyces. The invention also relates to novel DNA constructs, as well as compositions, cells and host organisms containing such sequences. FLP has been shown to rapidly and precisely recombine copies of its specific target sequence. FLP can be used to mosaically activate or inactivate transgenes for a variety of therapeutic purposes, as well as for analysis of vertebrate development.

Salk No: S95048
Patent Status: U.S. Patent No. 5,654,182 issued August 5, 1997
U.S. Patent No. 5,677,177 issued October 14, 1997
U.S. Patent No. 5,885,836 issued March 23, 1999
Publications: Science Vol. 251, pp. 1351-1355 (1991)
License Terms: Nonexclusive field of use licenses negotiable
Contact: Michelle Booden, Ph.D., Director of Licensing, 858.453.4100 x1612, mbooden@salk.edu

Get Involved

Sign up for our email newsletter

Fill out my online form.
Contact
Salk Institute for Biological Studies
Street: 10010 N Torrey Pines Rd
City: La Jolla, CA 92037
Email: webrequest@salk.edu
Phone: 858.453.4100
Charity Navigator Rating
  • Salk Twitter
  • Salk LinkedIn
  • Salk Facebook
  • Salk Instagram
  • Salk Google+
  • Salk YouTube
  • Salk RSS Feed
© Copyright 2014 Salk Institute for Biological Studies | Privacy Policy About Scientists & Research News & Media Events Support